Literature DB >> 4031265

Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction.

D G Mathey, F H Sheehan, J Schofer, H T Dodge.   

Abstract

To determine whether myocardial salvage after successful intracoronary or intravenous thrombolysis is time dependent, the relation between left ventricular wall motion and the time to treatment was studied in 69 patients admitted less than 3 hours after onset of acute transmural myocardial infarction (42 patients with reperfusion by intracoronary streptokinase, 27 by intravenous urokinase). A similar significant relation between the time to treatment and the severity of regional hypokinesia at follow-up was found in the intracoronary and intravenous groups. To better define this relation, particularly during the early phase of infarction, the groups were combined. In patients in whom thrombolytic treatment was initiated within 2 hours after symptom onset, wall motion at follow-up was within 2 standard deviations of the normal mean in 82% (14 of 17 patients). If treatment was started 2 to 5 hours after symptom onset, the probability of improved wall motion decreased to 46% (24 of 52 patients, p less than 0.025). The time/wall motion relation appeared to be independent of infarct location, angiographically visible collateral vessels and the presence of subtotal coronary artery occlusion. The severity of hypokinesia at follow-up study correlated with the magnitude of peak serum creatine kinase (r = -0.71), indicating that thrombolytic therapy initiated within 2 hours after the onset of symptoms improves regional left ventricular function and reduces infarct size more than later therapy does.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031265     DOI: 10.1016/s0735-1097(85)80107-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

Review 1.  Treating myocardial infarction in the post-GUSTO era. A European perspective.

Authors:  M J de Boer; F Zijlstra
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

2.  A challenge to the nuclear cardiology laboratory: imaging goals in patients after infarction.

Authors:  T P Rocco; M A Pfeffer
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

3.  [Questionnaire for patients with ischaemic cardiopathy on their reaction to various alarm symptoms].

Authors:  J López de la Iglesia; E Martínez Ramos; L Pardo Franco; S Escudero Alvarez; R I Cañón de la Parra; M T Costas Mira
Journal:  Aten Primaria       Date:  2003-03-15       Impact factor: 1.137

4.  Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.

Authors:  J Owen; K D Friedman; B A Grossman; C Wilkins; A D Berke; E R Powers
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 5.  Cardiac ischemia. Part II--Reperfusion and treatment.

Authors:  G A Langer; G D Buckberg; J H Tillisch
Journal:  West J Med       Date:  1987-07

6.  Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.

Authors:  J L Anderson
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Assessment of left ventricular function in a randomised study of intravenous anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Preliminary results of the European Multicentre Study (Belgian Centres).

Authors:  Y Taeymans; P Materne
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Reasons for patients' delay in response to symptoms of acute myocardial infarction.

Authors:  A T Wielgosz; R P Nolan; J A Earp; E Biro; M B Wielgosz
Journal:  CMAJ       Date:  1988-11-01       Impact factor: 8.262

9.  Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of Royal College of Physicians of London.

Authors:  J S Birkhead
Journal:  BMJ       Date:  1992-08-22

10.  Distal coronary hemoperfusion and prolonged balloon inflation for acute occlusion: occurring during percutaneous transluminal coronary angioplasty.

Authors:  J Heibig; S Harris
Journal:  Tex Heart Inst J       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.